Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, India; University School of Medicine and Paramedical Health Sciences, Guru Gobind Singh Indraprastha University, New Delhi, Dwarka 110078, India.
ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi 110029, India.
Diagn Microbiol Infect Dis. 2024 Sep;110(1):116398. doi: 10.1016/j.diagmicrobio.2024.116398. Epub 2024 Jun 12.
Carbapenem-resistant significant members of Acinetobacter calcoaceticus-Acinetobacter baumannii (CR-SM-ACB) complex have emerged as an important cause of sepsis, especially in ICUs. This study demonstrates the application of loop-mediated-isothermal-amplification (LAMP) assay for detection of CR-SM-ACB-complex from patients with sepsis. Whole-blood and culture-broths(CB) collected from patients with culture-positive sepsis were subjected to LAMP and compared with PCR, and RealAmp. Vitek-2 system and conventional PCR results were used as confirmatory references. The sensitivity and specificity of LAMP(97 % & 100 %) and RealAmp(100 % & 100 %) for detection of CR-SM-ACB-complex from CB were better than PCR(87 % & 100 %). Diagnostic accuracy of LAMP, RealAmp, and PCR for detection of SM-ACB-complex from CB was 98.5 %, 100 %, and 88.5 % respectively. Turnaround time of Culture, LAMP, PCR, and RealAmp was 28-53, 6-20, 9-23, and 6-20hours, respectively. LAMP is a simple, inexpensive tool that can be applied directly to positive CB and may be customized to detect emerging pathogens and locally-prevalent resistance genes and to optimize antimicrobial use.
产碳青霉烯酶的鲍曼不动杆菌复合群(CR-SM-ACB)的重要成员已成为败血症的重要病因,尤其是在 ICU 中。本研究展示了环介导等温扩增(LAMP)检测败血症患者中 CR-SM-ACB 复合群的应用。从培养阳性败血症患者采集的全血和培养肉汤(CB)标本进行 LAMP 检测,并与 PCR 和 RealAmp 进行比较。Vitek-2 系统和常规 PCR 结果被用作确证参考。LAMP(97%和 100%)和 RealAmp(100%和 100%)对 CB 中 CR-SM-ACB 复合群的检测灵敏度和特异性优于 PCR(87%和 100%)。LAMP、RealAmp 和 PCR 对 CB 中 SM-ACB 复合群检测的诊断准确性分别为 98.5%、100%和 88.5%。培养、LAMP、PCR 和 RealAmp 的周转时间分别为 28-53、6-20、9-23 和 6-20 小时。LAMP 是一种简单、廉价的工具,可以直接应用于阳性 CB,并可定制用于检测新出现的病原体和当地流行的耐药基因,并优化抗菌药物的使用。